Senseonics Announces CE Mark Approval Of The Eversense E3 Continuous Glucose Monitoring System
Senseonics Holdings, Inc. (NYSE:SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today